What is biomarker testing for cancer?
What is biomarker testing for cancer?
Biomarker testing for cancer looks at genes, proteins, and other substances in your cancer that can inform treatment. Some targeted therapies and immunotherapies only work when a cancer has certain biomarkers. It also goes by tumour testing, genomic profiling, molecular profiling, somatic testing.
This is not clinical evidence and not medical advice. It does not replace your care team. Discuss anything here with your clinician before you act on it. Product questions are on the FAQ.
Made by Triangle.
Biomarker testing looks for genes, proteins and other substances in your cancer that can help you and your doctor choose a treatment. It differs from inherited genetic testing, and an old report can go stale.
Is biomarker testing the same as genetic testing for inherited risk?
No. Biomarker testing looks at changes in the cancer itself, most of which arose during your lifetime and cannot be passed on. Inherited (germline) testing looks for mutations you were born with that raise cancer risk. Some biomarker tests can incidentally suggest an inherited change. That usually means a separate test and a genetic counsellor.
When do doctors suggest biomarker testing?
Often for cancer that has spread or come back, and routinely at diagnosis for certain types, including non-small cell lung cancer, breast cancer, and colorectal cancer. It is worth asking whether it should be part of your care, and whether your insurance covers it.
How is the test done?
A sample of the cancer, taken during surgery or by biopsy, or a blood draw for blood cancers or a liquid biopsy. A specialised lab returns a report of the biomarkers found and any treatments that may match. Some tests also need a sample of your healthy cells for comparison.
What can the results show?
That your cancer has a biomarker targeted by a known therapy: approved, off-label, or in a trial. Or that it has a biomarker that would stop a therapy working, which can spare you a treatment unlikely to help. Often it finds changes that do not affect treatment decisions.
What does variant of unknown significance mean?
A genetic change whose effect is not known. Along with changes thought to be harmless, these are not used to make treatment decisions.
Can biomarker testing help me find a clinical trial?
Sometimes. Some studies enrol people based on the biomarkers in their cancer rather than where it started (basket trials). Some studies include biomarker testing as part of the trial.
Why might a test not help?
The biopsy may be unsafe or too small. No biomarker may match an available therapy. A matching therapy may be off-label and not covered, or only in a trial you cannot join. Even a match may not work: not all cancer cells share the same biomarkers, and other features of your body affect how a drug behaves.
Is an old biomarker report still valid?
Not necessarily. The biomarkers in a cancer can change. A test is a snapshot of one moment. Your provider may want to retest, for example if the cancer comes back. Mine was re-read from the raw data, not just the summary.
Who pays for biomarker testing?
It varies with the test, the cancer, and the plan. For advanced cancer, some tests are covered by Medicare and Medicaid. Private insurers often cover a test when there is enough evidence it is needed to guide treatment. Tests without that evidence may be treated as experimental and not covered.
See how Triangle reads sequencing alongside your records →
Sources
- NCI: Biomarker Testing for Cancer TreatmentBiomarker testing is a way to look for genes, proteins, and other substances that can provide information about cancer; some cancer treatments, including targeted therapies and immunotherapies, may only work for people whose cancers have certain biomarkers; it may also be called tumor testing, genomic testing or profiling, molecular testing or profiling, or somatic testing.
- NCI: Biomarker Testing for Cancer TreatmentBiomarker testing is different from genetic testing used to find inherited mutations; somatic mutations arose during your lifetime and can't be passed on; some biomarker tests can find inherited changes, which may need another genetic test to confirm, and a provider may recommend a genetic counselor.
- NCI: Biomarker Testing for Cancer TreatmentBiomarker testing is done for many people with cancer that has spread or come back after treatment, and routinely to select treatment for certain types, including non-small cell lung cancer, breast cancer, and colorectal cancer; it's a good idea to check whether insurance covers it.
- NCI: Biomarker Testing for Cancer TreatmentA sample is taken during surgery or by biopsy, or by blood draw for blood cancer or a liquid biopsy; a special lab creates a report listing the biomarkers and any treatments that might work; some gene tests also need a sample of healthy cells.
- NCI: Biomarker Testing for Cancer TreatmentResults may show a biomarker targeted by a known therapy (FDA-approved, off-label, or in a clinical trial), or one that may prevent a therapy from working; many tests find changes that won't help treatment decisions.
- NCI: Biomarker Testing for Cancer TreatmentGenetic changes thought to be harmless (benign) or whose effects are not known (variant of unknown significance) are not used to make treatment decisions.
- NCI: Biomarker Testing for Cancer TreatmentSome studies enroll people based on the biomarkers in their cancer instead of where it started, sometimes called basket trials; for other trials biomarker testing is part of the study.
- NCI: Biomarker Testing for Cancer TreatmentTesting may not help if a biopsy can't be done safely, there isn't enough tumor tissue, no biomarker matches an available therapy, or a match would be off label and not covered; not all cancer cells have the same biomarkers, and features of your body can affect how well a treatment works.
- NCI: Biomarker Testing for Cancer TreatmentBiomarkers can change over time and a test is a snapshot; past results may not reflect the cancer now; a provider may want to test again, for example if the cancer comes back.
- NCI: Biomarker Testing for Cancer TreatmentCost varies by test, cancer and plan; for advanced cancer some tests are covered by Medicare and Medicaid; private insurers often cover a test with enough proof it is required to guide treatment; tests without enough proof may be considered experimental and likely not covered.
- NCI: Genetic Testing for Inherited Cancer RiskGenetic testing for inherited cancer risk looks for specific inherited changes in a person's genes that may increase the risk of diseases such as cancer; testing of tumor cells is covered on NCI's biomarker testing page.
Triangle